Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee approves pharmacy chapter rewrite but strips two compounding labeling subsections
Summary
The Senate Health and Welfare Committee approved a comprehensive rewrite of the Idaho State Board of Pharmacy rules but voted to remove two labeling subsections related to distribution of compounded drug products after stakeholder concerns about access and federal guidance.
The Senate Health and Welfare Committee approved pending rule chapter IDAPA 24.36.01 (docket 24-3601-2402) from the Idaho State Board of Pharmacy on a motion that struck subsections identified as 214 E(i) and 214 E(ii).
The pending rule package, presented by Nikki Chopsky, bureau chief of health professions at the Division of Occupational and Professional Licenses and executive officer for the Idaho State Board of Pharmacy, consolidated and reorganized more than 35 rule changes across definitions, licensure, practice standards, discipline, fees, compounding, sterile preparations and prescription drug monitoring. "Following the passage of house bill 527 ... the board reviewed and adopted this temporary rule docket in March of 2024," Chopsky said during her presentation.
Committee members said the compounding and labeling language raised particular concern because the federal Food and Drug Administration had issued draft guidance but not a final rule. Senator…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
